Yonga G.O OGOLA E.N. Juma F.D Metabolic effects of popranolol and hydroflumethiazide in Kenyans with mild to moderate hypertension. East Africa Med J.70: 696,199Yonga G.O OGOLA E.N. Juma F.D Metabolic effects of popranolol and hydroflumethiazide in Kenyan

Citation:
N PROFOGOLAELIJAHS. "Yonga G.O OGOLA E.N. Juma F.D Metabolic effects of popranolol and hydroflumethiazide in Kenyans with mild to moderate hypertension. East Africa Med J.70: 696,199Yonga G.O OGOLA E.N. Juma F.D Metabolic effects of popranolol and hydroflumethiazide in Kenyan.". In: East Africa Med J.70: 696,1993. Kisipan, M.L.; 1993.

Abstract:

Sixty newly diagnosed adult patients with mild to moderate essential hypertension were assessed to determine their cardiovascular risk factor profiles. Detailed history and physical examinations were done. Resting 12-lead ECG was done and serum levels of uric acid, fasting cholesterol, and fasting glucose were determined. Twenty nine patients had hypertension and two or more cardiovascular risk factors. The most prevalent cardiovascular risk factors other than hypertension were electro-cardiovascular left ventricular hypertrophy (31.7%), obesity (28.3%) and hypercholesterolaemia (28.3%). About a half of these patients (48.3%) can be classified as high risk hypertensives. This calls for aggressive management of cardiovascular risk factors as a whole and not just hypertension alone if we are to reduce incidence of hypertensive complications.

Notes:

n/a

Website

UoN Websites Search